Active self-healing biomaterial system
Methods and compositions are provided that load and encapsulate an agent, such as a protein, in a porous self-healing polymer. A delivery system includes a porous self-healing polymer, an ionic affinity trap within the pores of the self-healing polymer, and an agent associated with the ionic affinity trap. Methods of encapsulating an agent in a polymer include providing a porous self-healing polymer comprising an ionic affinity trap within the pores. The polymer is incubated with an agent having an affinity for the ionic affinity trap. At least a portion of the pores in the polymer are then healed. Active encapsulation of macromolecules at low concentrations may be achieved due to affinity of the agent for the ionic affinity trap within the pores.
1. A method of making a delivery system comprising:
providing a biodegradable polymer matrix having an interconnected porous structure and an ionic affinity trap disposed within the pores of the porous structure, and no agent disposed within the porous structure;
absorbing an agent into the polymer matrix from a surrounding aqueous solution;
reversibly binding the agent to the ionic affinity trap; and
increasing the temperature of the biodegradable polymer matrix to at least its hydrated Tg and thereby partially or fully encapsulating the agent, wherein the agent is encapsulated at >50% encapsulation efficiency; wherein said agent comprises a biomolecule, drug, or antigen, and wherein said ionic affinity trap comprises aluminum hydroxide, aluminum phosphate, calcium phosphate, or alum,
wherein the providing a biodegradable polymer matrix having an interconnected porous structure and an ionic affinity trap disposed within the pores of the porous structure comprises preparing a water-in-oil-in-water double emulsion wherein the initial water phase comprises a porosigen and the ionic affinity trap and the oil phase comprises the biodegradable polymer.
2. The method of claim 1 , wherein the biodegradable polymer matrix comprises a copolymer of lactic acid and glycolic acid.
3. The method of claim 2 , wherein the ionic affinity trap comprises Al(OH) 3 gel.
4. The method of claim 1 , wherein the biomolecule comprises a protein, peptide, proteoglycan, lipoprotein, or nucleic acid.
5. The method of claim 1 , wherein the biodegradable polymer matrix further comprises a plasticizer.
6. The method of claim 1 , wherein the aqueous solution comprises less than about 5 mg/mL of the agent.
7. The method of claim 1 , wherein the agent is encapsulated at greater than 90% encapsulation efficiency.
8. The method of claim 2 wherein the biodegradable polymer matrix comprises poly(D,L-lactic-co-glycolic acid) 50:50.
9. The method of claim 5 wherein the plasticizer comprises diethyl phthalate.
10. The method according to claim 1 , wherein the ionic affinity trap comprises Ca 3 (PO 4 ) 2 or non-stoichiometric hydroxyapatite, Ca 10−x (HPO 4 ) x (PO 4 ) 6−x (OH) 2−x , where x varies from 0 to 2.
11. The method according to claim 1 , wherein the ionic affinity trap comprises aluminum phosphate.
12. The method according to claim 1 , wherein the ionic affinity trap comprises alum.
13. The method according to claim 1 , wherein the ionic affinity trap comprises an ionomeric gel.